ST. LOUIS – A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer’s ...

More Injectables Used During COVID Use of PRN injectable medications for the treatment of acute agitation increased in long-term care residents with dementia during the COVID-19 pandemic ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Getting treatment for anxiety Talking therapies can be effective for people in the early to middle stages of dementia. In psychological therapy or ‘talking therapy’ sessions, a person will be ...

Treatments currently available in the UK for Alzheimer’s disease focus mainly on controlling symptoms for people with mild to moderate disease, says Dr Athwal, adding there are currently no treatments ...

Behind the white picket fence of a weatherboard home in Hawthorn in Melbourne’s inner east, Luke Campbell was asleep on his ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

Getting treatment for anxiety Talking therapies can be effective for people in the early to middle stages of dementia. In psychological therapy or ‘talking therapy’ sessions, a person will be ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.